abstract |
The invention relates to quaternary α-aminocarboxyamide derivatives of formula (I) and their pharmaceutically salts or solvates (I) wherein R1 is H or CH3; and R2 is H or CH3, for treating diseases and conditions mediated by modulation of voltage-gated sodium channels. |